ibro 2007 presentation, page-9

Koko,

I am perplexed by the total silence of the company.
-Results of the ACV1 sciatica trial remain unreported
-No explanation of why the report is late
-Quarterly Investor Update at least a week overdue
-No release regarding the ACV1 presentation this weekend or the participation of the chief science officer

Uncertainty creates doubt, and people with doubts don't by shares.

Metabolic needs to make some sort of public statement soon. There won't be any kind of bull market in these shares until that happens.